Oh_2017_Diabetes.Obes.Metab_19_294

Reference

Title : Effects of renal impairment on the pharmacokinetics and pharmacodynamics of a novel dipeptidyl peptidase-4 inhibitor, evogliptin (DA-1229) - Oh_2017_Diabetes.Obes.Metab_19_294
Author(s) : Oh J , Kim AH , Lee S , Cho H , Kim YS , Bahng MY , Yoon SH , Cho JY , Jang IJ , Yu KS
Ref : Diabetes Obes Metab , 19 :294 , 2017
Abstract : Oh_2017_Diabetes.Obes.Metab_19_294
ESTHER : Oh_2017_Diabetes.Obes.Metab_19_294
PubMedSearch : Oh_2017_Diabetes.Obes.Metab_19_294
PubMedID: 27761990

Related information

Citations formats

Oh J, Kim AH, Lee S, Cho H, Kim YS, Bahng MY, Yoon SH, Cho JY, Jang IJ, Yu KS (2017)
Effects of renal impairment on the pharmacokinetics and pharmacodynamics of a novel dipeptidyl peptidase-4 inhibitor, evogliptin (DA-1229)
Diabetes Obes Metab 19 :294

Oh J, Kim AH, Lee S, Cho H, Kim YS, Bahng MY, Yoon SH, Cho JY, Jang IJ, Yu KS (2017)
Diabetes Obes Metab 19 :294